Literature DB >> 9834094

Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation.

F Zhang1, D Z Wang, M Boothby, L Penix, R A Flavell, T M Aune.   

Abstract

Before they can deliver their effector functions, CD4+ Th cells must differentiate into Th1 or Th2 subsets. We have prepared reporter transgenic mice that express the luciferase gene under the control of proximal (prox.IFN-gamma) and distal (dist.IFN-gamma) regulatory elements from the IFN-gamma promoter to permit investigation of mechanisms that regulate IFN-gamma gene transcription during Th cell differentiation. Precursor Th cells (pTh) contain high levels of cAMP response element binding protein-activation transcription factor-1 (CREB-ATF1) proteins that bind these promoter elements from the IFN-gamma gene, and these cells fail to express promoter activity. Restimulated effector Th (eTh) cells have reduced levels of CREB-ATF1 proteins, their nuclear extracts exhibit reduced CREB-ATF1 binding and greater Jun and Jun-ATF2 binding to dist.IFN-gamma), and eTh cells express promoter activity. CREB directly competes with effector T cell nuclear proteins for dist.IFN-gamma binding, and overexpression of CREB inhibits both prox.IFN-gamma- and dist.IFN-gamma-directed transcription in Jurkat T cells. IL-12-stimulated Thl differentiation increases dist.IFN-gamma activity in restimulated eTh1 cells; eTh1 nuclear extracts form increased levels of Jun-ATF2-dist.IFN-gamma complexes. Taken together, these data suggest that both de-repression and trans-activation contribute to the induction of IFN-gamma gene transcription during Th1 differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834094

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  The molecular basis of T cell differentiation.

Authors:  R A Flavell
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Signaling and cell death in lymphocytes.

Authors:  R A Flavell; C Dong; R J Davis
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

Review 3.  Transcriptional reprogramming during T helper cell differentiation.

Authors:  T M Aune
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development.

Authors:  Brendan Jones; Jianzhu Chen
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

5.  ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells.

Authors:  Xisheng Wang; Peter F Barnes; Karen M Dobos-Elder; James C Townsend; Yoon-tae Chung; Homayoun Shams; Stephen E Weis; Buka Samten
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

6.  CREB is a positive transcriptional regulator of gamma interferon in latent but not active tuberculosis infections.

Authors:  Yang Liu; Yan-Ling Guo; Shi-Jie Zhou; Fei Liu; Feng-Jiao Du; Xiao-Jing Zheng; Hong-Yan Jia; Zong-De Zhang
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

Review 7.  Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase.

Authors:  C Dong; R J Davis; R A Flavell
Journal:  J Clin Immunol       Date:  2001-07       Impact factor: 8.317

8.  Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells.

Authors:  Irene H Heijink; Edo Vellenga; Peter Borger; Dirkje S Postma; Jan G R de Monchy; Henk F Kauffman
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

9.  Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis.

Authors:  William Walker; Dino Rotondo
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

10.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.